Lionheart Health, Inc. has announced a special partnership with CoreViva to offer AI enhanced full body MRI to its Lionheart Klotho Wellness Program patients. CoreViva provides arguably the most advanced full body MRI scans with an FDA-cleared AI, which will serve as a critical baseline measurement for participants in Lionheart's healthspan optimization protocol.
The partnership comes as Lionheart Health is a semi-finalist in the $101 million Xprize Healthspan competition, having been selected among the final 40 out of 600 entries. The company's protocol focuses on elevating circulating klotho levels through a comprehensive approach including klotho-promoting meals home delivered, daily klotho supplements targeting gut health, brain health, muscle health and immunity boosting, and BodStim TM bioelectric klotho enhanced exercise.
Dr. Leslie Miller, Chief Medical Officer for Lionheart Health, Inc., stated that launching patients into the Lionheart Klotho Wellness Program with CoreViva's advanced AI analysis whole body MRI will provide a crucial baseline on their current health status, with follow-up scans planned at 12 months. The company aims to demonstrate improvement in muscle health, cardiovascular health including calcification reduction, immunity health and brain health through their studies.
CoreViva's mission to improve early detection and treatment of diseases through the best whole-body MRI, wellness education, and patient experience aligns with Lionheart's healthspan longevity goals at https://lionheartlongevity.com/licensing/. The AI-enhanced MRI technology represents a significant advancement in tracking physiological changes and validating the effectiveness of longevity interventions.
This collaboration marks an important step in quantifying healthspan improvements through objective imaging data, potentially setting new standards for measuring the efficacy of longevity protocols. The integration of advanced diagnostic technology with comprehensive wellness programming could provide valuable insights into aging processes and intervention effectiveness for the broader health and longevity industry.
